1. U.S. Department of Health and Human Services Food and Drug Administration, Center for Devices and Radiological Health and Center for Biologics Evaluation and Research. Patient Preference Information—Voluntary Submission, Review in Premarket Approval Applications, Humanitarian Device Exemption Applications, and De Novo Requests, and Inclusion in Decision Summaries and Device Labeling: Guidance for Industry, Food and Drug Administration Staff, and other Stakeholders. http://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm446680.pdf Accessed 24 Aug 2016.
2. Medical Device Innovation Consortium. A framework for incorporating information on patient preferences regarding benefit and risk into regulatory assessments of new medical technology. 2015. http://mdic.org/wp-content/uploads/2015/05/MDIC_PCBR_Framework_Web1.pdf.
3. Bridges JFP, de Bekker-Grob EW, Hauber AB, Heidenreich S, Janssen E, Bast A, Hanmer J, Danyliv A, Low E, Bouvy JC, Marshall DA. A roadmap for increasing the usefulness and impact of patient-preference studies in decision making in health: a good practices report of an ISPOR task force. Value Health. 2023;26(2):153–62.
4. Hauber AB, Marcos Gonzales J, Groothuis-Oudshoorn CGM, Prior T, Marshall DA, Cunningham C, IJzerman MJ, Bridges JFP. Statistical methods for the analysis of discrete-choice experiments: a report of the ISPOR Conjoint Analysis Good Research Practices Task Force. Value Health. 2016;19(4):300–15.
5. Johnson FR, Lancsar E, Marshall DA, Kilambi V, Mühlbacher A, Regier DA, Bresnahan BW, Kanninen B, Bridges JFP. Constructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task force. Value Health. 2013;16:3–13.